Is there alternative to radical cystectomy in treating patients with muscle-invasive low-grade bladder cancer?

Authors

  • P. G. Yakovlev O. Bohomolets National Medical University, Kyiv

DOI:

https://doi.org/10.11603/2414-4533.2019.2.10415

Keywords:

muscle-invasive bladder cancer, radical cystectomy, organ sparing surgery, trimodality treatment, overall survival

Abstract

The aim of the work: to assess the prevalence of bladder sparing surgeries (BSS) combined with perioperative treatment as alternative to radical cystectomy (RCE) in managing patients with urothelial high-grade muscle-invasive bladder cancer (HGMIBC), and assess their effect on overall survival.

Materials and Methods. Retrospectively analyzed data of 309 patients with urothelial HGMIBC: clinical stage of cancer; surgery performed: RCE, partial cystectomy (PCE), transurethral resection of bladder (TURB); use of radio- or chemotherapy after BSS; survival data.

Results and Discussion. 109 (35.3%) RCE and 200 (64.7%) BSS were performed. The overall survival after 5 years post treatment for stages II, III and IV after RCE was 43 %, 37 % and 10 %, after TURB – 58 %, 27 %, and 19 %, and after PCE – 53 %, 42 % and 40 %.
Ker

References

Bolenz, C., & Hautmann, R.E. (2019). Surgical treatment of bladder cancer: advances made in the past 50 years. Aktuelle Urol. DOI: 10.1055/a-0884-2792. DOI: https://doi.org/10.1055/a-0884-2792

Witjes, J.A., Bruins, M., Cathomas, R., Compérat, E., Cowan, N.C., Gakis, ..., & Veskimäe G. E.(2019). Muscle-invasive and metastatic bladder cancer. EAU Guidelines. Edn. presented at the EAU Annual Congress Barcelona: EAU Guidelines Office, Arnhem, The Netherlands.

Spencer, E.S., & Smith, A.B. (2015). Exploring the 3 A’s of cystectomy access to care for muscle-invasive bladder cancer. Urol. Oncol., 33, 105-107. DOI: https://doi.org/10.1016/j.urolonc.2014.11.014

Williams, S.B., Huo, J., Chamie, K., Hu, J.C., Giordano, S.H., Hoffman, K.E., ..., & Shih, Y.T. (2017). Underutilization of radical cystectomy among patients diagnosed with clinical stage T2 muscle-invasive bladder cancer. Eur. Urol. Focus., 3, 258-264. DOI: https://doi.org/10.1016/j.euf.2016.04.008

Martini, A., Sfakianos, J.P., Renström-Koskela, L., Mortezavi, A., Falagario, U.G., Egevad, L., ..., & Wiklund, N.P. (2019). The natural history of untreated muscle invasive bladder cancer. BJU Int. doi: 10.1111/bju.14872. DOI: https://doi.org/10.1111/bju.14872

Westergren, D.O., Gardmark, T., Lindhagen, L., Chau, A., & Malmström, P.U. (2019). A nationwide population based analysis of organ-confined muscle-invasive bladder cancer patients not receiving curative intent therapy in Sweden from 1997 to 2014. J. Urol. 101097JU0000000000000350. DOI: https://doi.org/10.1097/JU.0000000000000350

Coughlin, G.D., Youl, P.H., Philpot, S., Wright, M.J., Honore, M., & Theile, D.E. (2019). Outcomes following radical cystectomy: a population-based study from Queensland, Australia. ANZ J. Surg., 89, 752-757. DOI: https://doi.org/10.1111/ans.15259

Hautmann, R.E., de Petriconi, R.C., & Volkmer, B.G. (2011). 25 years of experience with 1,000 neobladders: long-term complications. J. Urol., 185, 2207-2212. DOI: https://doi.org/10.1016/j.juro.2011.02.006

Shabsigh, A., Korets, R., Vora, K.C., Brooks, C.M., Cronin, A.M., Savage, C., ..., & Donat, S.M. (2009). Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur. Urol., 55, 164-174. DOI: https://doi.org/10.1016/j.eururo.2008.07.031

Ploussard, G., Daneshmand, S., Efstathiou, J.A., Herr, H.W., James, N.D., Rödel, C.M., ..., & Kassouf, W. (2014). Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Eur. Urol., 66, 120-137. DOI: https://doi.org/10.1016/j.eururo.2014.02.038

Solsona, E., Iborra, I., Collado, A., Rubio-Briones, J., Casanova, J., & Calatrava, A. (2010). Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer. J. Urol., 184, 475-480. DOI: https://doi.org/10.1016/j.juro.2010.04.008

Korpics, M.C., Block, A.M., Martin, B., Hentz, C., Gaynor, E.R., Henry, E., ..., & Solanki, A.A. (2017). Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy. Cancer, 123, 3524-3531. DOI: https://doi.org/10.1002/cncr.30719

Edge, S.B., Byrd, D.R., Compton, C.C., Fritz, A.G., Greene, F.L., & Trotti, A. (2010). AJCC cancer staging manual (7th ed). New York, NY: Springer.

Yakovlev, P.G., & Klyushin, D.A. (2019). Vereshchako RI. Bladder sparing surgery in high-grade bladder cancer. Exp. Oncol., 41, 160-165. DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-2.13207

Yakovlev, P.G., & Klyushin, D.A. (2018). Lymphocyte count in peripheral blood is a sensitive tool in pretreatment assessment of patients with urological cancer. Experimental Oncology, 40, 1-5. DOI: https://doi.org/10.31768/2312-8852.2018.40(2):119-123

Williams, S.B., Kamat, A.M., Chamie, K., Froehner, M., Wirth, M.P., Wiklund, P.N., ..., & Thalmann, G.N. (2018). Systematic review of comorbidity and competing-risks assessments for bladder cancer patients. Eur. Urol. Oncol., 1, 91-100. DOI: https://doi.org/10.1016/j.euo.2018.03.005

James, N.D., Hussain, S.A., Hall, E., Jenkins, P., Tremlett, J., Rawlings, C., ..., & Huddart, R.A. (2012). Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N. Engl. J. Med., 366, 1477-1488. DOI: https://doi.org/10.1056/NEJMoa1106106

Fedorenko, Z.P., Hulak, L.O., Mykhaylovych, Yu.Y., Horokh, Ye.L., Ryzhov, A.Yu., Sumkina, O.V., & Kutsenko, L.B. (2018). Rak v Ukraini, 2017-2018. Zakhvoriuvanist, smertnist, pokaznyky diialnosti onkolohichnoi sluzhby [Cancer in Ukraine, 2017-2018. Morbidity, mortality, indicators of oncology service activity]. Biuleten Natsionalnoho kantser-reyestru Ukrainy № 20 ed: Natsionalnyi Instytut raku Ukrainy – Bulletin of the National Cancer Register of Ukraine. No. 20 ed: National Cancer Institute of Ukraine.

Song, Y.P., McWilliam, A., Hoskin, P.J., & Choudhury, A. (2019). Organ preservation in bladder cancer: an opportunity for truly personalized treatment. Nat. Rev. Urol. 20. Büchser, D., Zapatero, A., Rogado, J., Talaya, M., Martín de Vidales, C., Arellano, R., et al. (2019). Long-term Outcomes and Patterns of Failure Following Trimodality Treatment With Bladder Preservation for Invasive Bladder Cancer. Urology, 124, 183-190. DOI: https://doi.org/10.1016/j.urology.2018.07.058

Published

2019-09-10

How to Cite

Yakovlev , P. G. (2019). Is there alternative to radical cystectomy in treating patients with muscle-invasive low-grade bladder cancer?. Hospital Surgery. Journal Named by L.Ya. Kovalchuk, (2), 28–33. https://doi.org/10.11603/2414-4533.2019.2.10415

Issue

Section

ORIGINAL INVESTIGATIONS